img
SIRT2 is a tumor suppressor that connects aging acetylome cell cycle signaling and carcinogenesis     
Yazarlar
Park Seong-Hoon
Türkiye
Yuming Zhu
Türkiye
Prof. Dr. Özkan ÖZDEN
Kafkas Üniversitesi, Türkiye
Hyun-Seok Kim
Türkiye
Haiyan Jiang
Türkiye
Chu-Xia Deng
Türkiye
David Gius
Türkiye
Athanassios Vassilopoulos
Türkiye
Özet
One long standing observation in clinical oncology is that age increase is the single most statistically significant factor/variable that predicts for the incidence of solid tumors. This observation suggests that the cellular and molecular processes and mechanisms that direct an organism's life span may be used to determine the clinical connection between aging and carcinogenesis. In this regard, the genes that impact upon longevity have been characterized in S. cerevisiae and C. elegans, and the human homologs include the Sirtuin family of protein deacetylases. We have recently shown that the primary cytoplasmic sirtuin, Sirt2 appears to meet the criteria as a legitimate tumor suppressor protein. Mice genetically altered to delete Sirt2 develop gender-specific tumorigenesis, with females primarily developing mammary tumors, and males developing multiple different types of gastrointestinal malignancies. Furthermore human tumors, as compared to normal samples, displayed significant decreases in SIRT2 levels suggesting that SIRT2 may also be a human tumor suppressor.
Anahtar Kelimeler
Sirt2,sirtuins,acetylation,cancer,mitosis,APC/C complex
Makale Türü Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri)
Makale Alt Türü SCI, SSCI, AHCI, SCI-Exp dergilerinde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale
Dergi Adı Translational Cancer Research
Dergi ISSN 3431025
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce
Basım Tarihi 05-2012
Cilt No 1
Sayı 1
Sayfalar 15 / 21
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
WoS 88

Paylaş